Skip to main content

Medical Device Informatics Overview

RCHE has long track record on developing software solutions with medical device data for community driven safety improvement of medication administration. The Regenstrief National Center for Medical Device Informatics (REMEDI) is the flagship software solution that collects data from over 300 hospitals of infusion pump data from a broad range of manufacturers. In addition, RCHE has informatics system that links physiological monitoring device data with patient records in the RCHE data hub.

The Regenstrief National Center for Medical Device Informatics (REMEDI) is an evidence-based collaborative with a stated vision "To be a vibrant, resourceful and collaborative community that advances and promotes infusion pump medication administration in the interest of patient safety and quality." The mission and primary activity of the collaborative is to conduct activities that improve patient safety and quality of healthcare delivery. Activities include providing a vendor-neutral database of smart infusion pump data, for hospitals willing to share their data with others, and community activities focused on sharing information and best practices.

Why Infusion Pumps?

According to the FDA, in a 5-year period 2005 - 2009, there were 56,000 adverse events and numerous deaths associated with infusion devices ( Smart infusion pumps, those infusion pumps containing a library of medications with dosing guidelines are intended to ensure safe intravenous medication use by preventing over and under dosing, were in use by 72.9% of hospitals in 2013 (Fox, B. I., et al. "ASHP National Survey on Informatics: Assessment of the Adoption and Use of Pharmacy Informatics in U.S. Hospitals-2013." American Journal of Health-System Pharmacy, vol. 72, no. 8, 2015, pp. 636-655., doi: 10.2146/ajhp140274.). Since many hospital patients receive infusions, the REMEDI project was initiated in response to the national priority to improve patient safety for infusion pumps and to a request from the Indianapolis Coalition for Patient Safety.

Hospital members in 4 countries and 32 states leverage REMEDI to reduce the number of non-actionable alerts, define safe dosing guidelines, and increase clinician use of smart pump features. REMEDI's impact on patient safety has been noted in several journal articles and the collaborative was recognized for its work with a 2017 ISMP Cheers Award and for addressing a significant clinical care problem when it received the AAMI Foundation & Institute of Technology in Health Care's Clinical Solution Award. A coalition pharmacist describes the impact best, "REMEDI has been awesome to make our program safer as well as give us a benchmark for our program."

The Database and Community

With over 37 million alerts and compliance data representing nearly 160 million infusions, the database provides pharmacists, and other clinicians, evidence to make informed decisions related to infusion pump medication administration. Hospital users submit the following types of infusion pump data to REMEDI: 1) alert data generated when the clinician programs the pump outside the limits of the Dose Error Reduction Software (DERS); 2) the compliance data indicating how often clinicians use the smart pump features; and 3) their hospitals' drug limit libraries; and 4) operational alarm data. Tools allow REMEDI members to look at their data in unique and different ways and allow for deep dive analysis and benchmarking of other hospitals' pump data.

REMEDI participants include hospital clinicians (pharmacists, nurses, medication safety officers, etc.), infusion pump vendors, researchers, and others that support the mission and/or participate in community activities (ASHP, ECRI, AAMI, The Joint Commission, etc.). REMEDI hosts four conferences a year, one in-person and three "virtual," meetings and provides collaboration tools including a document repository and a discussion forum.

Ongoing Activities

Since the project started in 2010, the REMEDI development team has continued to provide new features and functions for the infusion pump collaborative, increased the capacity and performance of the system to support membership growth, and expanded capabilities to include physiological monitor and ventilator communities and data sharing. These data and collaboratives will continue to provide value to clinicians, vendors and researchers and, most importantly, advance patient safety and quality.